Background: False positive or negative examinations and high early recall rates are important factors in the performance of lung cancer screening programs. How low-dose chest tomography (LDCT) scans are interpreted and classified may impact these metrics. Method: LDCT examinations for participants in the Alberta Lung Cancer Screening Study (ALCSS) were interpreted by chest radiologist with information entered in a synoptic report. Baseline scans were classified according to highest risk of malignancy nodule as per the PAN-CAN nodule risk calculator (NRC) and according to the Lung-RADS scheme. A positive scan was any baseline LDCT requiring any intervention beyond an annual screening examination (NRC nodule with 5% malignancy risk; Lung-RADS category 3). In the calculation of sensitivity, false negative scans could include reader error or classification errors (NRC <5% or Lung-RADS <3 but cancer present regardless of perceived appropriateness of resulting management). Result: Seven hundred and seventy-six participants in the ALCSS underwent LDCT screening and had no prior chest CT imaging on file. Median follow-up was 572 days (+/-205) with lung cancer confirmed in 16 (2.1%) participants. The early recall rate was 9.0% for NRC and 11.2% for Lung-RADS (p¼0.044), with fair concordance between each approach (kappa 0.554). Sensitivity for malignancy was 87.5% vs. 87.5% (difference 0%, 95%CI -0.44%-0.44%) and specificity 92.6% vs. 90.4% (difference 2.2%, 95%CI 0.2%-4.3%) for NRC and Lung-RADS respectively. False negative screens were due to reader error (same case in both systems); and classification error (one different case for each system). Conclusion: Performance of both the NRC and Lung-RADS in the ALCSS was very good, with NRC resulting in a lower early recall rate. Application of the NRC demonstrated increased specificity over Lung-RADS without a change in sensitivity for lung cancer detection. Lung cancer program performance may be improved with the use of the PAN-CAN NRC classification.
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Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of NoneSmoking-Related Lung Cancer F.Z. Wu, T. En Kuei Radiology Department, Kaohsiung Veterans General Hospital, Kaohsiung City/TW Background: We proposed a modification of the ACR Lung Imaging Reporting and Data System (Lung-RADS) to clarify the characteristics of subsolid nodules with categories 1e11, and to compare the diagnostic accuracy with Lung-RADS and National Lung Screening Trial criteria in an Asian population with high prevalence of adenocarcinoma. Method:
We analyzed a retrospective cohort of 1978 consecutive healthy subjects (72.8% non-smoker) who underwent low-dose computed tomography from August 2013 to October 2014 (1084men, 894 women). Lung-RADS categories 2 and 3 were modified to include subcategories of 2A/2B/2Cand 3A/3B/3C, respectively. Clinical information and nodule characteristics were recorded. Receiver operating characteristic curves were used to compare diagnostic accuracy at different cutoffs.
Result: Thirty-two subjects (30 nonsmokers) had pathology-proven adenocarcinoma spectrum lesions in the follow-up period (1.6 ± 0.5 years). Modified Lung-RADS, using modified Lung-RADS category2C as cutoff, had an area under the curve (AUC) of 0.973 in predicting adenocarcinoma spectrumlesions (sensitivity of 100%, specificity of 89.3%), which was significantly higher than that of Lung-RADS (AUC ¼ 0.815, P < .001) and National Lung Screening Trial (AUC ¼ 0.906, P < .001). Furthermore, modified Lung-RADS showed an AUC of 0.992 in predicting invasive adenocarcinoma (sensitivity of95%, specificity of 97.8%) when category 3B was used as cutoff. Conclusion: Modified Lung-RADS may substantially improve sensitivity while maintaining specificity for detection of adenocarcinoma spectrum lesions in an Asian population. Compared to Lung-RADS, it has enhanced ability to differentiate invasive from indolent adenocarcinoma by more refined subclassification of subsolid nodules using two cutoff values of category 2C and 3B. The effect of using modified Lung-RADS in clinical practice must be carefully studied in prospective large cohortstudies.
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Discriminating Less Invasive Lesions of Early-Stage Lung Adenocarcinoma by Three-Dimensional Computed Tomography Analysis N. Yoshiyasu, F. Kojima, K. Hayashi, T. Bando Thoracic Surgery, St. Luke's International Hospital, Tokyo/JP Background: In the revised TNM classification for non-small cell lung cancer, the clinical T factor is specified by the maximum diameter and by the diameter of the solid component for subsolid nodules. However, as radiological measurement of the solid part is sometimes difficult, errors can occur among observers. If less invasive lesions can be truly predicted using computed tomography (CT) images, it will be very useful for determining treatment strategies. Hence, we investigated the ability to detect less invasive lesions in pathologically early-stage adenocarcinomas by evaluating the whole tumor based on three dimensional (3D) images from high-resolution CT (HRCT). Method: Among patients who underwent lung resections for primary lung cancer between February 2014 and December 2016 in our institution, we retrospectively reviewed 127 patients with pathological stage 0 or IA adenocarcinoma. All the lesions were divided into two groups: the less invasive group comprised adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), and the invasive group comprised invasive adenocarcinoma. Radiological occupied lesion volumes (cm 3 ) October 2018 Abstracts S571
